Drugs by condition
Drugs approved for acute pain
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
11
Still marketed, NDA or BLA
Drug classes
3
Novel drugs
4
New molecular entities and new biologics
In development
8
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for acute pain.
- Vyscoxa (Celecoxib) · Carwin Pharm Assoc Jul 29, 2025
- Journavx (Suzetrigine) · Vertex Pharms INC NovelBreakthrough therapyPriority reviewJan 30, 2025
- Combogesic (Acetaminophen, Ibuprofen) · Aft Pharms US Mar 1, 2023
- Licart (Diclofenac Epolamine) · Ibsa Inst Bio Dec 19, 2018
- Zipsor (Diclofenac Potassium) · Cosette Jun 16, 2009
All approved drugs for acute pain, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 91 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Nonsteroidal Anti-inflammatory Drug (3)
- Celebrex Celecoxib · Upjohn · 1998
- Vyscoxa Celecoxib · Carwin Pharm Assoc · 2025
- Combogesic Acetaminophen, Ibuprofen · Aft Pharms US · 2023
Sodium Channel Blocker (1)
- Journavx Suzetrigine · Vertex Pharms INC · 2025
Class not listed in FDA's data (7)
- Nucynta Tapentadol Hydrochloride · Collegium Pharm INC · 2008
- Naropin Ropivacaine Hydrochloride · Fresenius Kabi USA · 1996
- Licart Diclofenac Epolamine · Ibsa Inst Bio · 2018
- Zipsor Diclofenac Potassium · Cosette · 2009
- Morphine Sulfate Morphine Sulfate · Hikma · 2008
- Morphine Sulfate Morphine Sulfate · Hikma · 2008
- Flector Diclofenac Epolamine · Ibsa · 2007
Drugs in development for acute pain
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- CebranopadolTRN-228Phase 34 trials
Adneuris Therapeutics, Inc. · Pain, Acute Pain, Chronic Pain
- MR-107A-02Phase 31 trial
Viatris Specialty LLC · Acute Pain, Post Operative Pain, Pain
- matched to VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- GRT7040Phase 21 trial
Grünenthal GmbH · Acute Pain, Bunionectomy
- LTG-001Phase 21 trial
Latigo Biotherapeutics · Acute Pain, Postoperative
- LY4515100Phase 21 trial
Eli Lilly · Acute Pain, Molar, Molar, Third
- SRP-001Phase 21 trial
South Rampart Pharma, Inc. · Acute Pain, Postoperative Pain, Pain
2 discontinued brand-name drugs whose label still names it
More on acute pain: recruiting trials · published research
Related in pain and anesthesia: Neuropathic pain · Osteoarthritis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.